Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Could Scientist Find Drug to Treat His Own Disease?
How a researcher’s 12-year journey to a new Bristol-Myers psoriasis medicine became personal: “You have hopes and daydreams almost in some ways.” Source link
Hospitals Shutter Maternity Wards Amid Falling Birthrates
Women have fewer delivery options in rural, aging parts of the U.S. Source link
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
Drug Shortages Are a Boon to One Industry: Compounding Pharmacies
Hospitals increasingly rely on a sector that can start making drugs without FDA approval—and investment is pouring in. Source link
Pfizer’s Covid Boost Crashes to Earth
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
First Pill for Postpartum Depression Is Approved by FDA
The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial. Source link
The Political Turf Battle Over the Future of Your Prime Rib
The White House must decide whether the Food and Drug Administration or Agriculture Department will oversee the food-company scientists tweaking genes to make animals heat
Employers Cut Off Access to Weight-Loss Drugs for Workers
Costs are mounting for popular drugs such as Wegovy, a cousin of Ozempic, and healthcare plans are restricting coverage to save money. Source link
Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall
The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. Source link
Biogen to Buy Reata in $7.3 Billion Deal
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link